Rapid and efficient screening for p53 gene mutations by dideoxy fingerprinting.
Dideoxy fingerprinting (ddF) is an efficient method for detecting single base and other sequence changes in PCR-amplified DNA segments. This screening method is a hybrid between single-strand conformation polymorphism analysis (SSCP) and Sanger dideoxy sequencing. It involves a Sanger sequencing reaction with one dideoxynucleotide followed by non-denaturing gel electrophoresis. We are using ddF to screen for mutations in the p53 tumor suppressor gene in primary breast cancers. ddF detected more than 100 mutations in different regions of the gene, including all types of single-base mutations and microdeletions/microinsertions of various sizes. Furthermore, ddF reliably detected heterozygous mutations, if the region of interest was screened in both directions. In a blinded, prospective study, ddF detected all 25 mutations within exons 4-10 and adjacent flanking intronic regions previously found by direct sequencing. ddF was also useful in scoring two common polymorphisms within the p53 gene. Guidelines for preventing false-positive and false-negative results are summarized.
Blaszyk
H
H
Mayo Clinic and Foundation, Rochester, MN, USA.
Hartmann
A
A
Schroeder
J J
JJ
McGovern
R M
RM
Sommer
S S
SS
Kovach
J S
JS
D001943:Breast Neoplasms / Q000235:genetics; D016172:DNA Fingerprinting / Q000379:methods*; D016158:Genes, p53 / Q000235:genetics*; D006580:Genetic Carrier Screening / Q000379:methods; D005820:Genetic Testing / Q000379:methods*; D009154:Mutation / Q000235:genetics; D011110:Polymorphism, Genetic / Q000235:genetics